Industry Experts blogging about Dry Eye Disease
In a recent pre-publication release in the "Cornea" journal, tear osmolarity showed both treatment response and evidence of lower variability compared with other commonly used signs of Dry Eye Disease (DED). The study included DED patients being treated over a 3 month period utilizing topical cyclosporine 0.05% (Restasis). By … [Read more...]
A dry eye clinic can be a very important part of a comprehensive ophthalmology practice. By Sheldon Herzig, MD, FRCSC Dry eye syndrome (DES) has increasingly become a major concern, particularly as eye care specialists face growing numbers of cases arising from iatrogenic causes like PRK and LASIK. It has … [Read more...]
Asymptomatic MGD is more common than Symptomatic according to an article soon to be published in IOVS. In fact asymptomatic patients were more than two times more prevalent than those with symptoms. This publication is significant as it demonstrates if clinicians rely only symptoms of meibomian gland disfunction before evaluating … [Read more...]
Pre-op TearLab testing proves effective in selecting patients at risk for Dry Eye complications post-op according to Dr. Beatrice Cochener's presentation at the winter ESCRS recently, She discusses opportunities of pre-treating with Restasis, omega 3's. To see the full article published in OCULAR SURGERY NEWS EUROPE … [Read more...]
Dry Eye Disease is the most common pathology you will see in your clinic each day. Dr. Kelly Nichols addressed the need for clinicians to answer the call. From Contact Lenses Today: http://www.cltoday.com/new/issue_012212.asp Unmet Need in Dry Eye A recent "Industry News" article in the AOA News caught my … [Read more...]
In January's edition of Cataract and Refractive Surgery Today, Jay Pepose, MD, PhD says.... A lot depends on treating patients with dry eye disease. Nearly one in five individuals in North America has dry eye disease (DED); it may be one of the most common yet frequently undiagnosed and untreated problems seen every day by … [Read more...]
SAN DIEGO, January 24, 2012 -- TearLab Corporation (NASDAQ:TEAR; TSX:TLB) ("TearLab" or the "Company") announced today that, after reviewing and accepting labeling submitted to it by the Company, the U.S Food and Drug Administration (“FDA”) has now granted Waiver categorization under the Clinical Laboratory Improvement … [Read more...]
Normal subjects showed no variation over a day, confirming that a properly functioning tear film is characterized by its low and stable concentration. This study provides further evidence that eye-to-eye variability is the hallmark of Dry Eye Disease. As shown in Lemp et al. [AJO 2011], dry eye disease subjects showed … [Read more...]
See this weeks Practice Pearl from Paul Karpecki, OD where he discusses the many diagnostic instruments he would like to include in his "dream dry eye practice". He mentions the TearLab Osmolarity System, among others. http://www.revoptom.com/email/010912_pearl86_v2.html … [Read more...]
Biomarkers are becoming more and more important in patient care and this article by Elyse Chaglasian, OD presents multiple examples how eye care practitioners can care for their patients..... http://www.reviewofcontactlenses.com/content/c/31008/ … [Read more...]
